Enhancement of the efficacy of synthetic and natural anticancer agents through nanocarrier for colon cancer treatment

被引:2
作者
Mukherjee, Kaushik [1 ]
Dutta, Pallobi [1 ]
Dey, Sourav [1 ]
Giri, Tapan Kumar [1 ]
机构
[1] Jadavpur Univ, Dept Pharmaceut Technol, Kolkata 700032, West Bengal, India
来源
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS | 2024年 / 10卷
关键词
Colon cancer; Nanocarriers; Monoclonal antibodies; Anticancer agents; ACID PHENETHYL ESTER; COLORECTAL-CANCER; GOLD NANOPARTICLES; DRUG-DELIVERY; POLYMERIC NANOPARTICLES; ANTIOXIDANT ACTIVITY; THERAPEUTIC TARGET; CARBON NANOTUBES; IN-VITRO; LIPOSOMES;
D O I
10.1016/j.ejmcr.2024.100137
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Colon cancer ranks third amongst type of cancer and second in terms of mortality. Various natural and synthetic anticancer agents have been used for the treatment of colon cancer. However, most anticancer agents have poor aqueous solubility and thus low absorptions and bioavailability. Moreover, the chemotherapeutic agents are unable to differentiate between normal and healthy cells and thus kill both types of cells. Nanocarriers have surfaced as a budding anticancer agent delivery system that could enhance the solubility and bioavailability of the anticancer agents and at the same time specifically deliver them to the cancerous cells. In this regard, gold, polymeric, and solid lipid nanoparticles, dendrimers, liposomes, niosomes, and carbon nanotubes have shown promising results as targeted anticancer drug delivery agents with enhanced bioavailability. The objective of this review article is to highlight these nanocarriers and present a detailed overview of how they have enhanced the efficacy of both synthetic and natural anticancer agents.
引用
收藏
页数:17
相关论文
共 130 条
  • [71] Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
    Lamb, Rebecca
    Ozsvari, Bela
    Lisanti, Camilla L.
    Tanowitz, Herbert B.
    Howell, Anthony
    Martinez-Outschoorn, Ubaldo E.
    Sotgia, Federica
    Lisanti, Michael P.
    [J]. ONCOTARGET, 2015, 6 (07) : 4569 - 4584
  • [72] Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy
    Lee, Chang-Seuk
    Kim, Hyungjoo
    Yu, Joonhee
    Yu, Su Hwan
    Ban, Seona
    Oh, Seunghyun
    Jeong, Dongjun
    Im, Jungkyun
    Baek, Moo Jun
    Kim, Tae Hyun
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 142 : 416 - 423
  • [73] Preparation of Caffeic Acid Phenethyl Ester-Incorporated Nanoparticles and Their Biological Activity
    Lee, Hyo-Young
    Jeong, Young-Il
    Kim, Eun Jin
    Lee, Kyung Dong
    Choi, Seon-Hee
    Kim, Yun Jin
    Kim, Da Hye
    Choi, Ki-Choon
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (01) : 144 - 154
  • [74] Lee Sang W, 2009, Clin Colon Rectal Surg, V22, P218, DOI 10.1055/s-0029-1242461
  • [75] Enhanced Efficacy of Artemisinin Loaded in Transferrin-Conjugated Liposomes versus Stealth Liposomes against HCT-8 Colon Cancer Cells
    Leto, Isabella
    Coronnello, Marcella
    Righeschi, Chiara
    Bergonzi, Maria Camilla
    Mini, Enrico
    Bilia, Anna Rita
    [J]. CHEMMEDCHEM, 2016, 11 (16) : 1745 - 1751
  • [76] Role of phytochemicals in colorectal cancer prevention
    Li, Yu-Hua
    Niu, Yin-Bo
    Sun, Yang
    Zhang, Feng
    Liu, Chang-Xu
    Fan, Lei
    Mei, Qi-Bing
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (31) : 9262 - 9272
  • [77] EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer
    Li, Yuan
    Du, Yang
    Liang, Xiaolong
    Sun, Ting
    Xue, Huadan
    Tian, Jie
    Jin, Zhengyu
    [J]. NANOSCALE, 2018, 10 (35) : 16738 - 16749
  • [78] Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells
    Liszbinski, Raquel B.
    Romagnoli, Graziela G.
    Gorgulho, Carolina M.
    Basso, Caroline R.
    Pedrosa, Valber A.
    Kaneno, Ramon
    [J]. MATERIALS, 2020, 13 (02)
  • [79] Protecting the normal in order to better kill the cancer
    Liu, Bingya
    Ezeogu, Lewis
    Zellmer, Lucas
    Yu, Baofa
    Xu, Ningzhi
    Liao, Dezhong Joshua
    [J]. CANCER MEDICINE, 2015, 4 (09): : 1394 - 1403
  • [80] Targeted delivery of irinotecan to colon cancer cells using epidermal growth factor receptor-conjugated liposomes
    Liu, Yongwei
    Li, Xinghui
    Pen, Renqun
    Zuo, Wei
    Chen, Ya
    Sun, Xiuying
    Gou, Juhua
    Guo, Qianwen
    Wen, Maoling
    Li, Wuqi
    Yu, Shuangjiang
    Liu, Hao
    Huang, Min
    [J]. BIOMEDICAL ENGINEERING ONLINE, 2022, 21 (01)